Scholars Central

Search Scholars Central

Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.

Advanced searchHide advanced search

In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:

Years

1–25 of 28 articles for Retinal implant systems

Then save them, add them to a collection or cite them together.
  1. Conference abstract · 16 Oct 2017

    ULTRA LOW POWER BIOSENSORS: VLSI TRENDS AND FUTURE SCOPE

    Cardiovascular implantable devices such as defibrillators, pacemakers; Neural devices like deep brain stimulation (DBS) and prostheses for central nervous system (CNS), peripheral nervous system (PNS), cochlear and…

  2. Short communication · 31 Jul 2020

    Diabetes 2018: Treatment of Diabetic Macular Edema with ILUVIEN (Fluocinolone Acetonide 0.19mg): Pharmacokinetics and Lipophilicity for the Primary Care Provider: Alyson Evans- Alimera Sciences

    Journal of Diabetic Complications & Medicine · Volume 5, Issue 3

    inflammatory cytokines and biochemical factors driven by local and systemic disease processes (Figure 1). For the PCP, management of the systemic disease is an important part of preventing ocular complications…

  3. Editorial · 2019

    Stem Cell Research 2018-First-Year Results of Subretinal Mesenchymal Stem Cell Implantation in Severe Retinitis Pigmentosa- Ayse Oner- Erciyes University

    Insights in Stem Cells · Volume 5, Issue 4

    four types of stem/progenitor cells; retinal progenitor cells, ESCs, induced pluripotent SCs (iPSCs) and mesenchymal SCs (MSCs), that have been used in retinal diseases all having pros and cons ... them had systemic…

  4. Conference abstract · 4 Dec 2017

    Retinal Stem Cells Reprogramming

    Homotoxicology-Pharmaceuticals blend Therapy: through retrobulbar injections. The author reports his experience

  5. Research article · 2 Apr 2018

    A 2-year retrospective study of the treatment of retinal vein occlusion with dexamethasone 0.7 mg intravitreal implant (Ozurdex®): an emphasis on combination therapy.

    Journal of Clinical Ophthalmology · Volume 2, Issue 1

    Vein Occlusion (RVO) is the second commonest retinal vascular pathology after diabetic retinopathy. Ozurdex is a sustained-release 0.7 mg dexamethasone intravitreal implant which has been approved to treat adults…

  6. Conference abstract · 4 Dec 2017

    Interesting Retinal Cases

    started. Condition deteriorated, underwent vitrectomy both eyes, improved but reported ten months later with retinal detachment and cataract LE, underwent cataract extraction with RD surgery. At 2 years review vision…

  7. Conference abstract · 15 Mar 2017

    A new model for developing intravitreal formulations

    tend to be fast-acting, selective and potent. New dosage forms and drug delivery systems (DDSs) are also being developed to augment the treatment of chronic blinding conditions ... implants derived from non-protein low…

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels